Vieta, Eduard

Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder. [electronic resource] - International clinical psychopharmacology 03 2019 - 76-83 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1473-5857

10.1097/YIC.0000000000000246 doi


Adult
Akathisia, Drug-Induced--drug therapy
Antidepressive Agents
Antipsychotic Agents--adverse effects
Combined Modality Therapy
Depressive Disorder, Major--drug therapy
Dopamine Agonists--adverse effects
Female
Headache
Humans
Male
Middle Aged
Piperazines--adverse effects
Suicide
Treatment Outcome
Young Adult